OpenEvidence closed a $735M Series D in January 2026 to push its physician-facing clinical search across more than 40% of US doctors, the largest deployment in the category. Ambience Healthcare reached $243M Series C as the leading ambient-scribe product against Suki AI's $70M and a still-private Heidi AI. Tempus and Recursion straddle this category and ai-drug-discovery, while Lunit and Harrison.ai dominate AI radiology in oncology and chest imaging respectively. Glass Health and K Health build clinical-decision-support layers on top of the EHR, and Color Health rebuilt cancer-care navigation around an AI copilot. FDA 510(k) clearances for AI-as-medical-device are now flowing at a record pace.
CATEGORY
Best Medical AI Tools
48 tools compared · 2026
Ambient scribes, clinical search, and FDA-cleared imaging tools deployed at the point of care
48 ai medical startups tracked, with the largest concentration in US. Total tracked funding: $5.3B.
Tracked
48
Total Raised
$5.3B
Countries
10
Active Deals
0
1 
Treeline Biosciences Stamford, US $1.1B 2 
Aidoc Tel Aviv, Israel $500M 3 
Qure.ai — $123M 4 
Eko Health — $41M 5 
Color Health US $482M 6 
Suki — $73M 7 
Neko Health Stockholm, SE $325M 8 
VideaHealth Boston, US $60M 9 
Quibim Valencia, ES $50M 10 
NVision Ulm, DE $120M 11 
Navina — $55M 12 
voize Berlin, DE $50M
Funding by year — AI Medical
2020 → 2026Market overview
Key trends 2026
- Ambient scribes reach saturation pricing. Suki, Ambience, and Heidi compete at $200-400/clinician/mo, down from $600+ a year ago.
- OpenEvidence becomes the doctor-facing search default. $735M Series D funds outpaces any UpToDate-replacement attempt before it.
- FDA AI/ML 510(k) clearances accelerate. 2024-2026 device list growth tracks above 200/year, vs ~30/year pre-2020.
Benchmarks vs global
Largest 2026 round
$735M (OpenEvidence Series D)
vs $243M Ambience Series C ↑
Ambient scribe seat price
$200-400/mo
vs $600+/mo in 2024 ↓
FDA AI/ML device clearances
200+/yr (2024-26)
vs ~30/yr pre-2020 ↑
Top countries
By startup countStage breakdown
Latest round typeTop investors backing AI Medical
See all →FAQ
Frequently asked
How is ai-medical different from ai-drug-discovery?
AI-medical covers point-of-care clinical tools — scribes, decision support, imaging, search (OpenEvidence, Ambience, Suki, Lunit). AI-drug-discovery covers preclinical R&D — molecular generation, target ID, protein folding (Recursion, Insilico, Chai). A few firms (Tempus, Recursion) operate in both.
Which AI medical startup has raised the most?
OpenEvidence leads at $735M total funding after its January 2026 Series D, focused on a clinical search product used by US physicians. Ambience Healthcare follows at $243M Series C for ambient documentation, then Suki AI at $70M.
Are these tools FDA-cleared?
It depends on intended use. Diagnostic imaging products (Lunit, Harrison.ai modules, NIRAMAI) carry FDA 510(k) or CE Mark clearance. Documentation and search tools (Ambience, Suki, OpenEvidence) typically operate as non-device clinical software, which has lighter regulatory requirements.
Recent rounds in AI Medical
All rounds →| Date | Startup | Round | Amount |
|---|---|---|---|
| May 2026 | NVision | Series B | $55M |
| Apr 2026 | Aidoc | Series E | $150M |
| Mar 2026 | XCath | Series C | $30M |
| Mar 2026 | Procode AI | Seed | $4M |
| Jan 2026 | OpenEvidence | Series D | $250M |
| Jan 2026 | Surgerii Robotics | Series D | $100M |
| Dec 2025 | Valerie Health | Series A | $30M |
| Dec 2025 | a2z Radiology AI | Seed | $4.5M |
All AI Medical startups
Page 2OpenEvidence
VerifiedAI medical assistant for clinicians
Raised
$735M
Stage
S-D
NIRAMAI Health Analytix
A novel AI-based medical device for early, accurate, portable, and privacy-aware breast cancer detection.
Valerie Health
AI front office for independent doctors' practices
Raised
$39M
Stage
S-A
Freed
AI clinician assistant that writes your notes so you can focus on patients
Raised
$34M
Stage
S-A
Mendaera
Handheld robotics and AI to bring precision to mainstream medical procedures
Raised
$90M
Stage
S-B
Aignostics
Raised
$34M
Stage
S-B
a2z Radiology AI
An intelligence layer for medical imaging, starting with comprehensive CT triage
Raised
$4.5M
Stage
Seed
XCath
Next-generation endovascular robotics and steerable neurovascular guidewires
Raised
$92M
Stage
S-C
Corti
Raised
$60M
Stage
S-B
Gestalt Diagnostics
AI-enabled digital pathology platform for cancer diagnosis
Raised
$7.5M
Stage
S-A
Develop Health
GenAI medication access: insurance verification and prior authorization, automated
Raised
$17.6M
Stage
S-A
Tortus
Raised
$4.2M
Stage
Seed
Basata
AI that automates referrals, scheduling, and patient intake for specialty practices
Raised
$21M
Stage
S-A
Lunit
Conquer cancer through cutting-edge AI for earlier detection and more precise oncology treatments.
Tempus
Tempus is an AI-powered precision medicine company transforming healthcare through data-driven insights and genomic testing.
Stage
IPO
Harrison.ai
Global leaders in AI-powered radiology and medical imaging, unlocking infinite medical capacity for healthcare systems worldwide.
Heidi AI
Your AI Care Partner for Modern Clinical Practice, supporting clinicians from documentation to decisions and follow-up.
K Health
K Health's AI Physician Mode integrates with top health systems to provide superior primary care with 24/7 access.
Procode AI
AI-powered revenue cycle management for surgical and specialty billing
Raised
$4M
Stage
Seed
Morphle Labs
Automated digital pathology hardware and AI for cancer diagnostics
Raised
$5M
Stage
S-A
Barreleye
Raised
$10M
Stage
S-A
Glass Health
AI-powered ambient scribing and clinical decision support for healthcare professionals.
Acurion
Raised
$4.3M
Stage
Seed
Ambience Healthcare
VerifiedThe AI operating system for healthcare
Raised
$345M
Stage
S-C